Related references
Note: Only part of the references are listed.Review of rodent models of attention deficit hyperactivity disorder
Samantha L. Regan et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2022)
Trace Amine-Associated Receptor 1 (TAAR1): A new drug target for psychiatry?
Seetal Dodd et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2021)
Animal models of attention-deficit hyperactivity disorder (ADHD)
Vikrant Rahi et al.
INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE (2021)
A new rat model of creatine transporter deficiency reveals behavioral disorder and altered brain metabolism
Lara Duran-Trio et al.
SCIENTIFIC REPORTS (2021)
Considering sex as a biological variable will require a global shift in science culture
Rebecca M. Shansky et al.
NATURE NEUROSCIENCE (2021)
Role of trace amine-associated receptor 1 in the medial prefrontal cortex in chronic social stress-induced cognitive deficits in mice
Yue Zhang et al.
PHARMACOLOGICAL RESEARCH (2021)
A single episode of stress during adolescence impairs short-term memory and increases risk behaviour in an animal model of attention-deficit/ hyperactivity disorder
Icaro Raony et al.
BEHAVIOURAL PROCESSES (2021)
Trace Amine-Associated Receptor 1 Contributes to Diverse Functional Actions of O-Phenyl-Iodotyramine in Mice but Not to the Effects of Monoamine-Based Antidepressants
Ioannis Mantas et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
The Action of TAAR1 Agonist RO5263397 on Executive Functions in Rats
Artem Dorotenko et al.
CELLULAR AND MOLECULAR NEUROBIOLOGY (2020)
TAAR1 and Psychostimulant Addiction
Jianfeng Liu et al.
CELLULAR AND MOLECULAR NEUROBIOLOGY (2020)
Exogenous 3-Iodothyronamine Rescues the Entorhinal Cortex from β-Amyloid Toxicity
Alice Accorroni et al.
THYROID (2020)
A Non-D2-Receptor-Binding Drug for the Treatment of Schizophrenia
Kenneth S. Koblan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Caffeine Consumption plus Physical Exercise Improves Behavioral Impairments and Stimulates Neuroplasticity in Spontaneously Hypertensive Rats (SHR): an Animal Model of Attention Deficit Hyperactivity Disorder
Angela Patricia Franca et al.
MOLECULAR NEUROBIOLOGY (2020)
Role of Neuropeptide S on Behavioural and Neurochemical Changes of an Animal Model of Attention-Deficit/Hyperactivity Disorder
Lisiane de Santana Souza et al.
NEUROSCIENCE (2020)
Caffeine and cannabinoid receptors modulate impulsive behavior in an animal model of attentional deficit and hyperactivity disorder
Douglas T. Leffa et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2019)
ADHD pathogenesis in the immune, endocrine and nervous systems of juvenile and maturating SHR and WKY rats
Anna Kozlowska et al.
PSYCHOPHARMACOLOGY (2019)
Systematic review and meta-analysis of the behavioral effects of methylphenidate in the spontaneously hypertensive rat model of attention-deficit/hyperactivity disorder
Douglas T. Leffa et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2019)
Trace Amine-Associated Receptor 1 Agonist Modulates Mismatch Negativity-Like Responses in Mice
Aleksander A. Aleksandrov et al.
FRONTIERS IN PHARMACOLOGY (2019)
8-OH-DPAT Induces Compulsive-like Deficit in Spontaneous Alternation Behavior: Reversal by MDMA but Not Citalopram
Anna U. Odland et al.
ACS CHEMICAL NEUROSCIENCE (2019)
Are hormones a female problem for animal research?
Rebecca M. Shansky
SCIENCE (2019)
Surgery Under General Anesthesia Alleviated the Hyperactivity but Had No Effect on the Susceptibility to PND in ADHD Rats
Peng Zhang et al.
FRONTIERS IN PSYCHIATRY (2019)
Region-specific interneuron demyelination and heightened anxiety-like behavior induced by adolescent binge alcohol treatment
James Rice et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2019)
Impact of developmental exposure to methylphenidate on rat brain's immune privilege and behavior: Control versus ADHD model
Vanessa Coelho-Santos et al.
BRAIN BEHAVIOR AND IMMUNITY (2018)
Transcranial direct current stimulation improves long-term memory deficits in an animal model of attention-deficit/hyperactivity disorder and modulates oxidative and inflammatory parameters
Douglas Teixeira Leffa et al.
BRAIN STIMULATION (2018)
Role of trace amine-associated receptor 1 in nicotine's behavioral and neurochemical effects
Jian-Feng Liu et al.
NEUROPSYCHOPHARMACOLOGY (2018)
The pharmacology of amphetamine and methylphenidate: Relevance to the neurobiology of attention-deficit/hyperactivity disorder and other psychiatric comorbidities
Stephen V. Faraone
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2018)
Characterization of Dopaminergic System in the Striatum of Young Adult Park2-/- Knockout Rats
Jickssa M. Gemechu et al.
SCIENTIFIC REPORTS (2018)
TAAR1 in Addiction: Looking Beyond the Tip of the Iceberg
Jian-Feng Liu et al.
FRONTIERS IN PHARMACOLOGY (2018)
Trace Amine Associated Receptor 1 (TAAR1) Modulation of Food Reward
Catherine F. Moore et al.
FRONTIERS IN PHARMACOLOGY (2018)
Striatal Tyrosine Hydroxylase Is Stimulated via TAAR1 by 3-Iodothyronamine, But Not by Tyramine or β-Phenylethylamine
Xiaoqun Zhang et al.
FRONTIERS IN PHARMACOLOGY (2018)
Biochemical and Functional Characterization of the Trace Amine-Associated Receptor 1 (TAAR1) Agonist RO5263397
Stefano Espinoza et al.
FRONTIERS IN PHARMACOLOGY (2018)
Development of a peptide targeting dopamine transporter to improve ADHD-like deficits
Terence K. Y. Lai et al.
MOLECULAR BRAIN (2018)
MEMRI reveals altered activity in brain regions associated with anxiety, locomotion, and cardiovascular reactivity on the elevated plus maze in the WKY vs SHR rats
Jasenka Zubcevic et al.
BRAIN IMAGING AND BEHAVIOR (2018)
The Trace Amine-Associated Receptor 1 Agonist RO5256390 Blocks Compulsive, Binge-like Eating in Rats
Antonio Ferragud et al.
NEUROPSYCHOPHARMACOLOGY (2017)
Trace amine-associated receptor 1 regulation of methamphetamine-induced neurotoxicity
Nicholas B. Miner et al.
NEUROTOXICOLOGY (2017)
Social factors affect motor and anxiety behaviors in the animal model of attention-deficit hyperactivity disorders: A housing-style factor
Meng-Li Tsai et al.
PSYCHIATRY RESEARCH (2017)
Trace Amine-Associated Receptor 1 Agonists as Narcolepsy Therapeutics
Sarah W. Black et al.
BIOLOGICAL PSYCHIATRY (2017)
Nicotine-induced behavioral sensitization in an adult rat model of attention deficit/hyperactivity disorder (ADHD)
Elizabeth Watterson et al.
BEHAVIOURAL BRAIN RESEARCH (2016)
Effects of high-frequency repetitive transcranial magnetic stimulation (rTMS) on spontaneously hypertensive rats, an animal model of attention-deficit/hyperactivity disorder
Jungyun Kim et al.
INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE (2016)
Versatile 3D-printed headstage implant for group housing of rodents
R. C. Pinnell et al.
JOURNAL OF NEUROSCIENCE METHODS (2016)
Attention deficit hyperactivity disorder
Anita Thapar et al.
LANCET (2016)
Rearing in an enriched environment attenuated hyperactivity and inattention in the Spontaneously Hypertensive Rats, an animal model of Attention-Deficit Hyperactivity Disorder
Chrislean Jun Botanas et al.
PHYSIOLOGY & BEHAVIOR (2016)
Adolescent d-amphetamine treatment in a rodent model of attention deficit/hyperactivity disorder: impact on cocaine abuse vulnerability in adulthood
Chloe J. Jordan et al.
PSYCHOPHARMACOLOGY (2016)
Discovery and Characterization of 2-Aminooxazolines as Highly Potent, Selective, and Orally Active TAAR1 Agonists
Guido Galley et al.
ACS MEDICINAL CHEMISTRY LETTERS (2016)
A Comprehensive Behavioral Test Battery to Assess Learning and Memory in 129S6/Tg2576 Mice
Andrea Wolf et al.
PLOS ONE (2016)
Nicotine-induced place conditioning and locomotor activity in an adolescent animal model of attention deficit/hyperactivity disorder (ADHD)
Elizabeth Watterson et al.
BEHAVIOURAL BRAIN RESEARCH (2015)
Common prefrontal cortical gene expression profiles between adolescent SHR/NCrl and WKY/NCrl rats which showed inattention behavior
Ike dela Pena et al.
BEHAVIOURAL BRAIN RESEARCH (2015)
Trace amine-associated receptor 1 activation silences GSK3β signaling of TAAR1 and D2R heteromers
Anja Harmeier et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2015)
Modulation by Trace Amine-Associated Receptor 1 of Experimental Parkinsonism, L-DOPA Responsivity, and Glutamatergic Neurotransmission
Alexandra Alvarsson et al.
JOURNAL OF NEUROSCIENCE (2015)
Prevalence of Attention-Deficit/Hyperactivity Disorder: A Systematic Review and Meta-analysis
Rae Thomas et al.
PEDIATRICS (2015)
Cocaine-seeking behavior in a genetic model of attention-deficit/hyperactivity disorder following adolescent methylphenidate or atomoxetine treatments
Chloe J. Jordan et al.
DRUG AND ALCOHOL DEPENDENCE (2014)
Taar1-mediated modulation of presynaptic dopaminergic neurotransmission: Role of D2 dopamine autoreceptors
D. Leo et al.
NEUROPHARMACOLOGY (2014)
Effect of treadmill exercise on social interaction and tyrosine hydroxylase expression in the attention-deficit/hyperactivity disorder rats
Dae-Jung Baek et al.
JOURNAL OF EXERCISE REHABILITATION (2014)
Oroxylin A improves attention deficit hyperactivity disorder-like behaviors in the spontaneously hypertensive rat and inhibits reuptake of dopamine in vitro
Seo Young Yoon et al.
ARCHIVES OF PHARMACAL RESEARCH (2013)
Pharmacological effects of 3-iodothyronamine (T1AM) in mice include facilitation of memory acquisition and retention and reduction of pain threshold
Maria Elena Manni et al.
BRITISH JOURNAL OF PHARMACOLOGY (2013)
Transgenic mouse models for ADHD
Damiana Leo et al.
CELL AND TISSUE RESEARCH (2013)
5,7-Dihydroxy-6-methoxy-4′-phenoxyflavone, a derivative of oroxylin A improves attention-deficit/hyperactivity disorder (ADHD)-like behaviors in spontaneously hypertensive rats
Ike C. dela Pena et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2013)
Caffeine regulates frontocorticostriatal dopamine transporter density and improves attention and cognitive deficits in an animal model of attention deficit hyperactivity disorder
Pablo Pandolfo et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2013)
A new perspective for schizophrenia: TAAR1 agonists reveal antipsychotic- and antidepressant-like activity, improve cognition and control body weight
F. G. Revel et al.
MOLECULAR PSYCHIATRY (2013)
Adolescent Atomoxetine Treatment in a Rodent Model of ADHD: Effects on Cocaine Self-Administration and Dopamine Transporters in Frontostriatal Regions
Sucharita S. Somkuwar et al.
NEUROPSYCHOPHARMACOLOGY (2013)
Trace Amine-Associated Receptor 1 Partial Agonism Reveals Novel Paradigm for Neuropsychiatric Therapeutics
Florent G. Revel et al.
BIOLOGICAL PSYCHIATRY (2012)
Clozapine decreases exploratory activity and increases anxiety-like behaviour in the Wistar-Kyoto rat but not the spontaneously hypertensive rat model of attention-deficit/hyperactivity disorder
Sarah Mc Fie et al.
BRAIN RESEARCH (2012)
Amfetamine and methylphenidate medications for attention-deficit/hyperactivity disorder: complementary treatment options
Paul Hodgkins et al.
EUROPEAN CHILD & ADOLESCENT PSYCHIATRY (2012)
The genetics of attention deficit/hyperactivity disorder in adults, a review
B. Franke et al.
MOLECULAR PSYCHIATRY (2012)
Brain-Specific Overexpression of Trace Amine-Associated Receptor I Alters Monoaminergic Neurotransmission and Decreases Sensitivity to Amphetamine
Florent G. Revel et al.
NEUROPSYCHOPHARMACOLOGY (2012)
Npas4: A Neuronal Transcription Factor with a Key Role in Social and Cognitive Functions Relevant to Developmental Disorders
Laurence Coutellier et al.
PLOS ONE (2012)
The Roles of Dopamine and Noradrenaline in the Pathophysiology and Treatment of Attention-Deficit/Hyperactivity Disorder
Natalia del Campo et al.
BIOLOGICAL PSYCHIATRY (2011)
The emerging role of trace amine-associated receptor 1 in the functional regulation of monoamine transporters and dopaminergic activity
Gregory M. Miller
JOURNAL OF NEUROCHEMISTRY (2011)
Functional Interaction between Trace Amine-Associated Receptor 1 and Dopamine D2 Receptor
Stefano Espinoza et al.
MOLECULAR PHARMACOLOGY (2011)
TAAR1 activation modulates monoaminergic neurotransmission, preventing hyperdopaminergic and hypoglutamatergic activity
Florent G. Revel et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Comparison of SHR, WKY and Wistar rats in different behavioural animal models: effect of dopamine D1 and alpha2 agonists
Barbara Langen et al.
ADHD-ATTENTION DEFICIT AND HYPERACTIVITY DISORDERS (2011)
Chronic caffeine treatment during prepubertal period confers long-term cognitive benefits in adult spontaneously hypertensive rats (SHR), an animal model of attention deficit hyperactivity disorder (ADHD)
Vanessa A. Pires et al.
BEHAVIOURAL BRAIN RESEARCH (2010)
Environmental enrichment reduces the impact of novelty and motivational properties of ethanol in spontaneously hypertensive rats
Cristiane Ribeiro de Carvalho et al.
BEHAVIOURAL BRAIN RESEARCH (2010)
Striatal volume changes in a rat model of childhood attention-deficit/hyperactivity disorder
Ju-Wei Hsu et al.
PSYCHIATRY RESEARCH (2010)
Predictive Validity of a Continuous Alternative to Nominal Subtypes of Attention-Deficit/Hyperactivity Disorder for DSM-V
Benjamin B. Lahey et al.
JOURNAL OF CLINICAL CHILD AND ADOLESCENT PSYCHOLOGY (2010)
Prevalence and correlates of adult attention-deficit hyperactivity disorder: meta-analysis
Viktoria Simon et al.
BRITISH JOURNAL OF PSYCHIATRY (2009)
A Receptor Mechanism for Methamphetamine Action in Dopamine Transporter Regulation in Brain
Zhihua Xie et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)
Novelty-induced locomotion is positively associated with cocaine ingestion in adolescent rats; anxiety is correlated in adults
Q. David Walker et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2009)
The selective antagonist EPPTB reveals TAAR1-mediated regulatory mechanisms in dopaminergic neurons of the mesolimbic system
Amyaouch Bradaia et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Environmental enrichment improves cognitive deficits in Spontaneously Hypertensive Rats (SHR): Relevance for Attention Deficit/Hyperactivity Disorder (ADHD)
Fabricio A. Pamplona et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2009)
Cannabinoid-induced conditioned place preference in the spontaneously hypertensive rat-an animal model of attention deficit hyperactivity disorder
Pablo Pandolfo et al.
PSYCHOPHARMACOLOGY (2009)
Advancing the spontaneous hypertensive rat model of attention deficit/hyperactivity disorder
K. M. Kantak et al.
BEHAVIORAL NEUROSCIENCE (2008)
Chronic methylphenidate treatment during adolescence increases anxiety-related behaviors and ethanol drinking in adult spontaneously hypertensive rats
Leandro F. Vendruscolo et al.
BEHAVIOURAL PHARMACOLOGY (2008)
Modulation of monoamine transporters by common biogenic amines via trace amine-associated receptor 1 and monoamine autoreceptors in human embryonic kidney 293 cells and brain synaptosomes
Zhihua Xie et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)
Trace amine associated receptor 1 and movement control
Tatyana D. Sotnikova et al.
PARKINSONISM & RELATED DISORDERS (2008)
Trace amine-associated receptor 1 modulates dopaminergic activity
Lothar Lindemann et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)
Increased sensitivity of adolescent spontaneously hypertensive rats, an animal model of attention deficit hyperactivity disorder, to the locomotor stimulation induced by the cannabinoid receptor agonist WIN 55,212-2
Pablo Pandolfo et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2007)
The usefulness of spontaneously hypertensive rat to model attention-deficit/hyperactivity disorder (ADHD) may be explained by the differential expression of dopamine-related genes in the brain
Qi Li et al.
NEUROCHEMISTRY INTERNATIONAL (2007)
Rhesus monkey trace amine-associated receptor 1 signaling: Enhancement by monoamine transporters and attenuation by the D2 autoreceptor in vitro
Zhihua Xie et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
Trace amine-associated receptor 1 is a modulator of the dopamine transporter
Zhihua Xie et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
Increased sensitivity to cocaine-induced analgesia in Spontaneously Hypertensive Rats (SHR)
Fabricio A. Pamplona et al.
BEHAVIORAL AND BRAIN FUNCTIONS (2007)
Caffeine improves spatial learning deficits in an animal model of attention deficit hyperactivity disorder (ADHD) - the spontaneously hypertensive rat (SHR)
RDS Prediger et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2005)
Novelty seeking and drug use: Contribution of an animal model
ME Cain et al.
EXPERIMENTAL AND CLINICAL PSYCHOPHARMACOLOGY (2005)
Molecular genetics of attention-deficit/hyperactivity disorder
SV Faraone et al.
BIOLOGICAL PSYCHIATRY (2005)
Animal models of attention-deficit hyperactivity disorder
Vivienne A. Russell et al.
BEHAVIORAL AND BRAIN FUNCTIONS (2005)
Ethological and temporal analyses of anxiety-like behavior: The elevated plus-maze model 20 years on
AP Carobrez et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2005)
The value of spontaneous alternation behavior (SAB) as a test of retention in pharmacological investigations of memory
RN Hughes
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2004)
Dissociation of hypertension and fixed interval responding in two separate strains of genetically hypertensive rat
JR Wickens et al.
BEHAVIOURAL BRAIN RESEARCH (2004)
Differential effects of novelty exposure on place preference conditioning to amphetamine and its oral consumption
Y Pelloux et al.
PSYCHOPHARMACOLOGY (2004)
Wistar-Kyoto rats are sensitive to the hypolocomotor and anxiogenic effects of mCPP
M Durand et al.
BEHAVIOURAL PHARMACOLOGY (2003)
Increased urine phenylethylamine after methylphenidate treatment in children with ADHD
A Kusaga et al.
ANNALS OF NEUROLOGY (2002)
Amphetamine, 3,4-methylenedioxymethamphetamine, lysergic acid diethylamide, and metabolites of the catecholamine neurotransmitters are agonists of a rat trace amine receptor
JR Bunzow et al.
MOLECULAR PHARMACOLOGY (2001)
Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method
KJ Livak et al.
METHODS (2001)
Trace amines: Identification of a family of mammalian G protein-coupled receptors
B Borowsky et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Individual differences in behavioral responses to novelty and amphetamine self-administration in male and female rats
JE Klebaur et al.
BEHAVIOURAL PHARMACOLOGY (2001)
Early androgen treatment decreases cognitive function and catecholamine innervation in an animal model of ADHD
JA King et al.
BEHAVIOURAL BRAIN RESEARCH (2000)